ADPT
Adaptive Biotechnologies Corporation · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +10.5% ·
flujo de acciones +1.3% ·
nuevas posiciones netas +9.5%
· fórmula
Acumulación amplia: acciones en aumento entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | -1 | 18.90K | $493,205 | n/a | −1 |
| Q2 2026 | 107 | 0 | 115.13M | $2.47B | +6 | −6 |
| Q1 2026 | 110 | +7 | 111.61M | $1.55B | +11 | −4 |
| Q4 2025 | 102 | 0 | 114.72M | $1.86B | +1 | −1 |
| Q3 2025 | 21 | +2 | 74.70M | $1.12B | +2 | n/a |
| Q2 2025 | 16 | +2 | 70.34M | $819.50M | +2 | n/a |
| Q1 2025 | 11 | 0 | 46.91M | $348.49M | +2 | −2 |
| Q4 2024 | 11 | -1 | 53.01M | $317.80M | n/a | −1 |
| Q3 2024 | 11 | +2 | 55.08M | $282.02M | +2 | n/a |
| Q2 2024 | 9 | n/a | 54.39M | $196.88M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Viking Global Investors ✦ | 29.99M | 0.0% | $448.71M | 1.2% | Held | 6 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 13.36M | -2.3% | $199.84M | 0.0% | ▼ Trim | 2 | SEC ↗ ×15 |
| 3 | The Vanguard Group ✦ (pasivo) | 11.28M | 0.0% | $168.68M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 4 | Geode Capital Management ✦ (pasivo) | 3.40M | +5.8% | $50.89M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | ARK Investment Management ✦ | 3.17M | -21.2% | $47.36M | 0.3% | ▼ Trim | 6 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (pasivo) | 3.08M | +1.7% | $46.07M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 2.44M | +544.0% | $36.52M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Goldman Sachs Group ✦ | 1.88M | n/a | $28.12M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 9 | T. Rowe Price ✦ | 1.09M | +790.1% | $16.27M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Morgan Stanley ✦ | 1.07M | n/a | $16.04M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 11 | D. E. Shaw & Co. ✦ | 738.18K | +21.4% | $11.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 609.00K | +40.8% | $9.11M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 13 | Wellington Management ✦ | 501.08K | Nuevo | $7.50M | 0.0% | New | 1 | SEC ↗ ×2 |
| 14 | JPMorgan Chase ✦ | 471.34K | n/a | $7.05M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 15 | Millennium Management ✦ | 397.31K | -60.8% | $5.94M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 324.50K | +11.5% | $4.85M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 17 | Point72 Asset Management ✦ | 319.47K | -76.8% | $4.78M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 279.70K | +460.5% | $4.18M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 151.25K | Nuevo | $2.26M | 0.0% | New | 1 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 127.06K | +76.8% | $1.90M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 28.08K | -96.5% | $420,137 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Wellington Management | $7.50M | 0.0% |
| Bridgewater Associates | $2.26M | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 295 tenedores, 151.59M acciones, $2.01B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 300 acc. · $7,635
Officer · 11.58K acc. · $280,376
Officer · 11.88K acc. · $304,272
Officer · 5.10K acc. · $131,682
Officer · 6.78K acc. · $173,390
Officer · 11.88K acc. · $302,966
Officer · 9.18K acc. · $232,738
Officer · 2.70K acc. · $70,389
Officer · 11.88K acc. · $313,777
Officer · 11.88K acc. · $304,866
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología